Japan Intellectual Property Rights: HIGH AFFINITY ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR GENERATION AND USE

Japan, Oct. 21 -- ADIMAB LLC has got intellectual property rights for 'HIGH AFFINITY ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR GENERATION AND USE.' Other related details are as follows:

Application Number: JP,2025-092374

Category (FI): A61K35/17,A61K39/395@D,A61K39/395@N,A61P25/00,A61P35/00,A61P37/02,A61P37/06,C07K16/28,C07K16/46,C07K7/06,C07K7/08,C12N1/15,C12N1/19,C12N1/21,C12N15/13,C12N15/62@Z,C12N5/10

Stage: Grant (IP right granted following substantive examination.)

Filing Date: June 3, 2025

Publication Date: Sept. 9, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.